PHILADELPHIA CHROMOSOME POSITIVE ACUTE LYMPHOBLASTIC LEUKEMIA PH+ ALL

Clinical trials for PHILADELPHIA CHROMOSOME POSITIVE ACUTE LYMPHOBLASTIC LEUKEMIA PH+ ALL explained in plain language.

Never miss a new study

Get alerted when new PHILADELPHIA CHROMOSOME POSITIVE ACUTE LYMPHOBLASTIC LEUKEMIA PH+ ALL trials appear

Sign up with your email to follow new studies for PHILADELPHIA CHROMOSOME POSITIVE ACUTE LYMPHOBLASTIC LEUKEMIA PH+ ALL, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1 Not yet finished but already full! 1

New hope for tough blood cancer: major trial tests promising drug combo

Disease control Ongoing

This study is testing whether a drug called ponatinib works better than the standard drug imatinib when both are given with lower-dose chemotherapy. It's for adults newly diagnosed with a fast-growing blood cancer called Philadelphia chromosome-positive acute lymphoblastic leukem…

Matched conditions: PHILADELPHIA CHROMOSOME POSITIVE ACUTE LYMPHOBLASTIC LEUKEMIA PH+ ALL

Phase: PHASE3 • Sponsor: Takeda • Aim: Disease control

Last updated Mar 23, 2026 15:15 UTC

PHILADELPHIA CHROMOSOME POSITIVE ACUTE LYMPHOBLASTIC LEUKEMIA PH+ ALL

Get alerted when new PHILADELPHIA CHROMOSOME POSITIVE ACUTE LYMPHOBLASTIC LEUKEMIA PH+ ALL trials appear

New hope for tough blood cancer: major trial tests promising drug combo